Literature DB >> 31284921

Epidemiology of Infections and Development of Asthma.

Jenny Resiliac1, Mitchell H Grayson2.   

Abstract

Asthma and allergic diseases have become more prevalent, although the reasons for this increase in disease burden are not known. Understanding why these diseases have become more common requires knowledge of the disease pathogenesis. Multiple studies have identified respiratory viral infections and atypical bacteria as potential etiologic agents underlying the development of asthma (and possibly allergies). This review discusses the epidemiology and potential mechanistic studies that provide links between these infectious agents and the development (and exacerbation) of asthma. These studies provide insight into the increase in disease prevalence and have identified potential targets for future therapeutic intervention.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; Asthma; Atypical bacteria; Epidemiology; Respiratory virus

Mesh:

Year:  2019        PMID: 31284921      PMCID: PMC6625524          DOI: 10.1016/j.iac.2019.03.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  70 in total

1.  National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2002-11       Impact factor: 10.793

2.  Rhinovirus illnesses during infancy predict subsequent childhood wheezing.

Authors:  Robert F Lemanske; Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Zhanhai Li; Peter A Shult; Carol J Kirk; Erik Reisdorf; Kathy A Roberg; Elizabeth L Anderson; Kirstin T Carlson-Dakes; Kiva J Adler; Stephanie Gilbertson-White; Tressa E Pappas; Douglas F Dasilva; Christopher J Tisler; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

3.  Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Authors:  Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

4.  Bronchiolitis-associated hospitalizations among US children, 1980-1996.

Authors:  D K Shay; R C Holman; R D Newman; L L Liu; J W Stout; L J Anderson
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 5.  Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review.

Authors:  E W Steyerberg; R de Groot; H A Moll
Journal:  Acta Paediatr       Date:  2000-06       Impact factor: 2.299

6.  Chlamydia pneumoniae and severity of asthma.

Authors:  Hertzen Leena Von; Tuula Vasankari; Kari Liippo; Eva Wahlström; Mirja Puolakkainen
Journal:  Scand J Infect Dis       Date:  2002

7.  Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis.

Authors:  A Munitz; E B Brandt; M Mingler; F D Finkelman; M E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

8.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 9.  The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations.

Authors:  Kecia N Carroll; Tina V Hartert
Journal:  Immunol Allergy Clin North Am       Date:  2008-08       Impact factor: 3.479

Review 10.  Effects of atypical infections with Mycoplasma and Chlamydia on asthma.

Authors:  Gregory Metz; Monica Kraft
Journal:  Immunol Allergy Clin North Am       Date:  2010-09-22       Impact factor: 3.479

View more
  7 in total

1.  Majie cataplasm provides a shield against asthmatic punch from the neuroimmune system.

Authors:  Wenting Ji; Xue Yu; Yushan Gao; Beida Ren; Shuang Zhang; Qingguo Wang; Xueqian Wang
Journal:  Heliyon       Date:  2020-05-23

2.  Allergy-related outcomes and sleep-related disorders in adults: a cross-sectional study based on NHANES 2005-2006.

Authors:  Yang Xi; Yu-Qin Deng; Shi-Ming Chen; Yong-Gang Kong; Yu Xu; Fen Li; Wo-Er Jiao; Gan Lu; Ze-Zhang Tao
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-22       Impact factor: 3.406

Review 3.  Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections.

Authors:  Armando S Flores-Torres; Amali E Samarasinghe
Journal:  Front Allergy       Date:  2022-03-25

Review 4.  Inactivation of FOXA2 by Respiratory Bacterial Pathogens and Dysregulation of Pulmonary Mucus Homeostasis.

Authors:  Woosuk Choi; Shawn Choe; Gee W Lau
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

5.  The mediatory role of Majie cataplasm on inflammation of allergic asthma through transcription factors related to Th1 and Th2.

Authors:  Wenting Ji; Qianyi Zhang; Hanfen Shi; Ruijuan Dong; Dongyu Ge; Xin Du; Beida Ren; Xueqian Wang; Qingguo Wang
Journal:  Chin Med       Date:  2020-05-24       Impact factor: 5.455

6.  Prevalence of atopic dermatitis, asthma and rhinitis from infancy through adulthood in rural Bangladesh: a population-based, cross-sectional survey.

Authors:  Courtney J Pedersen; Mohammad J Uddin; Samir K Saha; Gary L Darmstadt
Journal:  BMJ Open       Date:  2020-11-04       Impact factor: 2.692

Review 7.  Hypercapnia: An Aggravating Factor in Asthma.

Authors:  Masahiko Shigemura; Tetsuya Homma; Jacob I Sznajder
Journal:  J Clin Med       Date:  2020-10-05       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.